Inadequacies of current approaches to prediabetes and diabetes prevention

Endocrine

Volumn 44, Issue 3, 2013, Pages 623-633

  Bergman, Michael ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Non communicable diseases; Prediabetes; Prevention; Translation

Indexed keywords

ARTICLE; COMMUNITY CARE; CONTINUING EDUCATION; DIABETES MELLITUS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EARLY INTERVENTION; EDUCATION PROGRAM; EDUCATIONAL STATUS; HEALTH CARE COST; HEALTH PROMOTION; HOSPITAL CARE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; LONG TERM CARE; MEDICAL SCHOOL; NON COMMUNICABLE DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATIENT IDENTIFICATION; PREVENTIVE HEALTH SERVICE; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RESIDENCY EDUCATION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; STOMACH BYPASS; STRATEGIC PLANNING; SUGAR INTAKE;

DIABETES MELLITUS, TYPE 2; HEALTH PROMOTION; HUMANS; LIFE STYLE; OBESITY; PREDIABETIC STATE; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84890745230     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0017-9     Document Type: Article

References (87)

1. A. Albright, E.W. Gregg, Preventing type 2 diabetes in communities across the U.S. The National Diabetes Prevention Programs. Am. J. Prev. Med. 44(4S4), S346-S351 (2013)
2. H. Wang, L. Dwyer-Lindgren, K.T. Lofgren, J.K. Rajaratnam, J.R. Marcus, A. Levin-Rector, C.E. Levitz, A.D. Lopez, C.J.L. Murray, Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2071-2094 (2012)
3. S.H. Woolf, L.Y. Aron, The US health disadvantage relative to other high-income countries. Findings from a National Research Council/Institute of Medicine Report. JAMA 309(8), 771-772 (2013)
4. U.S. Health in International Perspective: Shorter Lives, Poorer Health (2013), ed by S. H. Woolf, L. Aron. Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine. http://www.nap.edu/openbook.php?record-id=13497&page=1. Accessed 17 July 2013
5. J.L. Kraschnewski, C.N. Sciamanna, H.L. Stuckey, C.H. Chuang, E.B. Lehman, K.O. Hwang, L.L. Sherwood, H.B. Nembhard, A silent response to the obesity epidemic. Decline in US physician weight counseling. Med. Care 51(2), 186-192 (2013)
6. J.A. Salomon, H. Wang, M.K. Freeman, T. Vos, A. Flaxman, A.D. Lopez, C.J.L. Murray, Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden disease Study 2010. Lancet 380(9859), 2144-2162 (2012)
7. S.S. Lim, A.D. Flaxman, G. Danaei, K. Shibuya, H. Adair-Rohani, M. Amann, H.R. Anderson, K.G. Andrews, M. Aryee et al., A comparative risk assessment of burden of disease and injury attributable to 67 risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2224-2260 (2012)
8. Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Healthy People 2020, ODPHP Publication No. B0132 (2010). http://www.hhs.gov/opa/title-x-family-planning/initiatives-and-resources/ healthy-people-2020/. Accessed 17 July 2013
9. R.H. Lustig, L.A. Schmidt, C.D. Brindis, The toxic truth about sugar. Nature 482(2), 27-29 (2012)
10. S. Basu, P. Yoffe, N. Hills, R.H. Lustig, The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One 8(2), 1-8 (2013)
11. I. Aeberli, M. Hochuli, P.A. Gerber, L. Sze, S.B. Murer, G.A.L. Tappy, G.A. Spinas, K. Berneis, Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men. Diabetes Care 36(1), 150-156 (2013)
12. G.A. Bray, Potential health risks from beverages containing fructose found in sugar or high-fructose corn syrup. Diabetes Care 36(1), 11-12 (2013)
13. M.J. Goran, S.J. Ulijaszek, E.E. Ventura, High fructose corn syrup and diabetes prevalence: a global perspective. Global Public Health 8(1), 55-64 (2013)
14. M. Moss, How the Food Giants Hooked Us (Random House, New York, 2013)
15. L.I. Lesser, F.J. Zimmerman, D.A. Cohen, Outdoor advertising, obesity, and soda consumption: a cross-sectional study. BMC Public Health 13(20), 1-7 (2013)
16. J.J. Shelley, Addressing the policy cacophony does not require more evidence: an argument for reframing obesity as caloric consumption. BMC Public Health 12(1), 1-8 (2012)
17. M.M. Slining, S.W. Ng, B.M. Popkin, Food companies' calorie-reduction pledges to improve U.S. diet. Am. J. Prev. Ned. 44(22), 174-184 (2013)
18. D. Yach, Nutritional change is not a simple answer to non-communicable diseases. BMJ (2011). doi: 10.1136bmj.d5097
19. K.M. Venkat Narayan, J.B. Echouffo-Tcheugui, V. Mohan, M.K. Ali, Global prevention and a control of type 2 diabetes will require paradigm shifts in policies within and among countries. Health Aff. 31(1), 1-8 (2012)
20. J.B. Echouffo, M.K. Ali, S.J. Griffin, K.M. Venkat Narayan, Screening for type 2 diabetes and dysglycemia. Epidemiol Rev (2011). doi: 10.1093/epirev/mxq020
21. L. Lianov, M. Johnson, Physician competencies for prescribing lifestyle medicine. JAMA 304(2), 202-203 (2010)
22. L.E. Fisher, R.E. Glasgow, A call for more effectively integrating behavioral and social science principles into comprehensive diabetes care. Editorials. Diabetes Care 30(10), 2746-2749 (2007)
23. M. Peyrot, R.R. Rubin, Behavioral and psychosocial interventions in diabetes. Diabetes Care 30(10), 2433-2440 (2007)
24. M.K. Ali, K. McKeever Bullard, J.B. Saaddine, C.C. Cowie, G. Imperatore, E.W. Gregg, Achievement of goals in U.S. diabetes care, 1999-2010. NEJM 368(17), 1613-1624 (2013)
25. K. Kostev, W. Rathmann, Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis. Diabetologia 56(1), 109-111 (2013)
26. P.G. Lee, C.T. Cigolle, J. Ha, L. Min, S.L. Murphy, C.S. Blaum, W.H. Herman, Physical function limitations among middle-aged and older adults with prediabetes. Diabetes Care (2013). doi: 10.2337/dc13-0412
27. C.M. Sanz, J.-B. Ruidavets, V. Bongard, J.-C. Marqie, H. Hanaire, J. Ferrieres, S. Andrieu, Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study. Diabetes Care (2013). doi: 10.2337/dc12-1017
28. J.M. Fletcher, M.R. Richards, Diabetes's 'Health Shock' to schooling and earnings: increased dropout rates and lower wages and employment in young adults. Health Aff. 31(1), 27-34 (2013)
29. J.M. McGinnis, W.H. Foege, The immediate vs the important. JAMA 291(10), 1263-1264 (2004)
30. K.E. Thorpe, The Affordable Care Act lays the groundwork for a national diabetes prevention and treatment strategy. Health Aff. 31(1), 61-66 (2012)
31. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 346(6), 393-403 (2002)
32. J.E. Fradkin, J.A. Wallace, G.P. Rodgers, Biomedical research. Paving a way to diabetes prevention. Am. J. Prev. Med. 44(4S4), S317-S323 (2013)
33. K.E. Thorpe, The Medicare advantage experience: lessons for reform to original Medicare. Rollins School of Public Health, Emory University (2012), http://www.scribd.com/doc/127623922/Statement-of-Kenneth-E-Thorpe-PhD-Hearing- On-Strengthening-Medicare-for-Today-and-the-Future. Accessed 17 July 2013
34. V.R. Aroda, R. Ratner, Approach to the patient with prediabetes. J. Clin. Endocrinol. Metab. 93(9), 3259-3265 (2008)
35. YanFeng Li, L.S. Geiss, N.R. Burrows, D.B. Rolka, A. Albright, Awareness of prediabetes-United States, 2005-2010. MMWR 62(11), 209-212 (2013)
36. D. Vojta, J. De Sa, T. Prospect, S. Stevens, Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer's perspective. Health Aff. 31(1), 20-25 (2012)
37. C. Villarivera, J. Wolcott, A. Jain, Y. Zhang, C. Goodman, The US Preventive Services Task Force should consider a broader evidence base in updating its diabetes screening guidelines. Health Aff. 31(1), 35-42 (2012)
38. J. Fradkin, Confronting the urgent challenge of diabetes: an overview. Health Aff. 31(1), 12-19 (2012)
39. M. Bergman, M. Buysschaert, P.E.H. Schwarz, A. Albright, K.M. Venkat Narayan, D. Yach, Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag. 2(4), 1-13 (2012)
40. R.M. Cohen, S. Haggerty, W.H. Herman, HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J. Clin. Endocrinol. Metab. 95(12), 5203-5206 (2010)
41. W.H. Herman, R.M. Cohen, Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J. Clin. Endocrinol. Metab. 97(4), 1067-1072 (2012)
42. S.A. Mostafa, M.J. Davies, B.T. Srinivasan, M.E. Carey, D. Webb, K. Khunti, Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation? Postgrad. Med. J. 86(10), 656-662 (2010)
43. D.H. Morris, K. Khunti, F. Achana, B. Srinivasan, L.J. Gray, M.J. Davies, D. Webb, Progression rates from HbA1c 6.0-6.4 % and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56(4), 1489-1493 (2013)
44. L. Perreault, S.E. Kahn, C.A. Christophi, W.C. Knowler, R.F. Hamman, The Diabetes Prevention Program Research Group, Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention program. Diabetes Care 32(9), 1583-1588 (2009)
45. R.W. Grant, K.E. O'Brien, J.L. Waxler, J.L. Vassy, L.M. Delahanty, L.G. Bissett, R.C. Green, K.G. Stember, C. Guiducci, E.R. Park, J.C. Florez, J.B. Meigs, Personalized genetic risk counseling to motivate diabetes prevention. Diabetes Care 36(1), 13-19 (2013)
46. M.-F. Hivert, K.A. Jablonski, L. Perreault, R. Saxena, J.B. McAteer, P.W. Franks, R.F. Hamman, S.E. Kahn, S. Haffner, The DIAGRAM Consortium, J.B. Meigs, D. Altshuler, W.C. Knowler, J.C. Florez, The Diabetes Prevention Program Research Group, Diabetes 60(4), 1340-1348 (2011)
47. J. Lindstrom, M. Peltonen, J.G. Eriksson, P. Ilanne-Parikka, S. Aunola, S. Keinanen-Kiukaanniemi, M. Uusitupa, J. Tuomilehto, The Finnish Diabetes Prevention Study (DPS), Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomized Finnish Diabetes Prevention Study (DPS). Diabetologia 56(2), 284-293 (2013)
48. W.C. Knowler, S.E. Fowler, R.F. Hamman, C.A. Christophi, H.J. Hoffman, A.T. Brenneman, J.O. Brown-Friday, R. Goldberg, E. Venditti, D.M. Nathan, Diabetes Prevention Program Research Group, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702), 1677-1686 (2009)
49. T. Saaristo, L. Moilanen, E. Korpi-Hyövälti, M. Vanhala, J. Saltevo, L. Niskanen, J. Jokelainen, M. Peltonen, H. Oksa, J. Tuomilehto, M. Uusitupa, S. Keinänen-Kiukaanniemi, Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national Diabetes Prevention Program (FIN-D2D). Diabetes Care 33(10), 2146-2155 (2010)
50. D.E. Arterburn, A. Bogart, N.E. Sherwood, S. Sidney, K.J. Coelman, S. Haneuse, P.J. O'Connor, M.K. Theis, G.M. Campos, D. McCulloch, J. Selby, A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes. Surg. 23(11), 93-102 (2013)
51. J.B. Dixon, Lee-Ming Chuang, K. Chong, Shu-Chun chen, G.W. Lambert, N.E. Straznicky, E.A. Lambeert, Wei-Jei Lee, Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 36(1), 20-26 (2013)
52. S. Yoneda, S. Uno, H. Iwahashi, Y. Fujita, A. Yoshikawa, J. Kozawa, K. Okita, D. Takiuchi, H. Eguchi, H. Nagano, A. Imagawa, I. Shimomura, Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes. J. Clin. Endocrinol. Metab. 98(5), 2053-2061 (2013)
53. M. Bergman, R. Dankner, J. Roth, K.M. Venkat Narayan, Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches. Endocrine (2013). doi: 10.1007/s12020-013-9873-6
54. L. Perreault, Q. Pan, K.J. Mather, K.E. Watson, R.F. Hamman, S.E. Kahn, The Diabetes Prevention Program Research Group, Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379(9833), 2243-2251 (2012)
55. R. Dankner, M. Bergman, A. Danoff, S. Qureshi, I. Whitford, N. Kaviani, Y. Dynkevich, J. Roth, The metabolic deterioration that antedates diabetes: personal trajectories of HbA1c and fasting glucose as early indicators and possible triggers for intervention. Diabetes Metab Res Rev Reviews 29(1), 1-7 (2013). doi: 10.1002/dmrr.2373
56. T. Higgins, HbA1c for screening and diagnosis if diabetes mellitus. Endocrine (2012). doi: 10.1007/s12020-012-9768-y
57. Y. Heianza, Y. Arase, K. Fujihara, H. Tsuji, K. Saito, S.D. Hsieh, S. Kodama, H. Shimano, N. Yamada, S. Hara, H. Sone, Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA1c and impaired fasting glucose. the Toranomon Hospital Health Management Center Study 4 (TOPCS 4). Diabetes Med. 29(9), e279-e285 (2012). doi: 10.1111/j.1464-5491.2012.03686
58. R. Dankner, J. Roth, A. Danoff, Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing. Editorial. Diabetes Metab. Res. Rev. 26(1), 7-9 (2010)
59. W.J. Kim, C.Y. Park, 1,5-Anhydroglucitol in diabetes mellitus. Endocrine (2012). doi: 10.1007/s12020-012-9760-6
60. M. Bergman, Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab. Res. Rev. 26(1), 3-6 (2010)
61. A. Karve, R.A. Hayward, Prevalence, diagnosis, and treatment of impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 33(11), 2355-2359 (2010)
62. E. Selvin, M.W. Steffes, H. Zhu, Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 362(9), 800-811 (2010)
63. K.M. Narayan, M.K. Ali, J.P. Koplan, Global noncommunicable diseases-where worlds meet. N. Engl. J. Med. 363(13), 1196-1198 (2010)
64. L. Siminerio, J.C. Mbanya, Translating diabetes research into global communities. Diabetes Res. Clin. Pract. 93(3), 443-445 (2011)
65. J. Segura, L.M. Ruilope, Treatment of pre-hypertension in diabetes and metabolic syndrome: what are the pros? Diabetes Care 32(Suppl 2), S284-S289 (2009)
66. R. DeFronzo, M. Abdul-Ghani, Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 108(suppl), 3B-24B (2011)
67. L. Niskanen, T. Hedner, L. Hansson, J. Lanke, A. Niklason, for the CAPP Study Group, Diabetes Care 24(12), 2091-2096 (2001)
68. E.N. Taylor, F.B. Hu, G.C. Curhan, Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 29(5), 1065-1070 (2006)
69. C. Manrique, M. Johnson, J.R. Sowers, Thiazide diuretics alone or with β-blockers impair glucose metabolism in hypertensive patients with abdominal obesity. Hypertension 55(1), 15-17 (2010)
70. W.J. Elliott, P.M. Meyer, Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369(9557), 201-207 (2007)
71. N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, A.J.M. de Craen, S.R.K. Seshasai, J.J. McMurray, D.J. Freeman, J.W. Jukema, P.W. Macfarlane, C.J. Packard, D.J. Stott, R.G. Westendorp, J. Shepherd, B.R. Davis, S.L. Pressel, R. Marchioli, R.M. Marfisi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J. Kjekhus, T.R. Perdersen, T.J. Cook, A.M. Gotto, M.B. Clearfield, J.R. Downs, H. Nakamura, Y. Ohashi, K. Mizuno, I. Ford, Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet 375(9716), 735-742 (2010)
72. A. Goldfine, Statins: is it really time to reassess benefits and risk? N. Engl. J. Med. 366(19), 1752-1755 (2012)
73. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, R.J. Glynn, Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380(9841), 565-571 (2012)
74. G.T. McMahon, R.G. Dluhy, Diabetes report card - time for a winning streak. N Engl J Med 368(17), 1650-1651 (2013)
75. M. Stellefson, K. Dipnarine, C. Stopka, The chronic care model and diabetes management in US primary care settings: a systematic review. Prev. Chronic Dis. (2013). doi: 10.5888/pcd10.120180
76. F.J. Crosson, J. Leu, B.M. Roemer, M.N. Ross, Gaps in residency training should be addressed to better prepare doctors for a twenty-first-century delivery system. Health Aff. 30(11), 2142-2148 (2011)
77. K.C. Stange, S.H. Woolf, K. Gjeltema, One minute for prevention, the power of leveraging to fulfill the promise of health behavior counseling. Am. J. Prev. Med. 22(4), 320-323 (2002)
78. J.E. Fielding, S.M. Teutsch, Integrating clinical care and community health. JAMA 302(3), 317-319 (2009)
79. J.K. Ockene, E.A. Edgerton, S.M. Teutsch, L.N. Marion, T. Miller, J.L. Genevro, C.J. Loveland-Cherry, J.E. Fielding, P.A. Briss, Integrating evidence-based clinical and community strategies to improve health. Am. J. Prev. Med. 32(3), 244-252 (2007)
80. R.S. Thompson, S.H. Taplin, T.A. McAfee, M.T. Mandelson, A.E. Smith, Primary and secondary prevention services in clinical practice. Twenty years' experience in development, implementation, and evaluation. JAMA 273(14), 1130-1135 (1995)
81. K.M. Venkat Narayan, D.F. Williamson, Prevention of type 2 diabetes: risk status, clinic and community. J. Gen. Intern. Med. 25(2), 154-157 (2009)
82. S.D. Pruitt, J.E. Epping-Jordan, Preparing the 21st century global healthcare workforce. BMJ 330(7492), 637-639 (2005)
83. P. Absetz, R. Valve, B. Oldenburg, H. Heinonen, A. Nissinen, M. Fogelheim, V. Ilvesmäki, M. Talja, A. Uutela, Type 2 diabetes prevention in the "real world". One-year results of the GOAL implementation trial. Diabetes Care 30(10), 2465-2470 (2007)
84. M.K. Ali, J.B. Echouffo-Tchegui, D.F. Williamson, How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff. 31(1), 67-75 (2012)
85. Grants. gov. Natural Experiments and Effectiveness Studies to Identify the Best Policy and System Level Practices to Prevent Diabetes and Its Complications (U58) [Internet]. Atlanta (GA): Centers for Disease Control and Prevention (2010), http://www.grants.gov/search/search.do?mode=VIEW&oppId= 51980. Accessed 5 Dec 2011
86. M.C. Seidel, R.O. Powell, J.C. Zgibor, L.M. Siminerio, G.A. Piatt, Translating the Diabetes Prevention Program into an urban medically underserved community. Diabetes Care 31(4), 684-689 (2008)
87. H. Holman, Chronic disease-the need for a new clinical education. JAMA 292(9), 1057-1059 (2004)